concluding that dosages of opioids and sedatives were not associated with time to death in end-of-life withdrawal of mechanical ventilation and/or vasoactive support (MV/VS).
First, the small sample size could not exclude a type II error in the statistical interpretation of results. A large epidemiological survey suggested a positive association between prescribed dosages of opioids and related death in the United States. 2 Second, large cumulative quantities and dosages of opioids and sedatives were given to patients 1 with no documentation of the type, frequency, or severity of distressing symptoms being treated. If practice dictated titrating medications to preemptively induce unconsciousness and respiratory depression before MV/VS withdrawal in all patients, the association between the dose and the time to death might be difficult to discern. These end points would be proximate surrogates of early death within 60 minutes. Other reports suggest that opioids, sedatives, and neuromuscular blocking agents may be administered to alleviate the distress experienced by families and care providers from the dying process after terminal withdrawal of MV. 3, 4 Finally, if extreme severity of illness alone explained the rapid death after MV/VS withdrawal, 1 patients would be most likely moribund or imminently dying of multipleorgan failure. The number of acutely failing organs predicted a short time to death. 5 The metabolic derangement of multiple-organ failure alters pharmacokinetics and pharmacodynamics of opioids and sedatives. 6 Impaired hepatic and renal clearance can result in cumulative buildup of plasma concentrations of opioids and sedatives administered either intermittently or by a continuous infusion. Acute metabolic encephalopathy can potentiate the actions of opioids and sedatives on the central nervous system and precipitate or accelerate terminal respiratory and circulatory arrest. 7 Pharmacologic potentiation of opioids and sedative effects on respiration and circulation can shorten the time to death. Drug kinetics and pharmacologic responses are critical factors for administering opioids and sedatives in proportional doses to control distressing symptoms and minimize the risk of causing death by disproportional dosing. The variability of pharmacokinetics and pharmacodynamics of opioids and sedatives in dying patients must be taken into account when determining the association between medication dosages and the time to death. DOI: 10.1213/ANE.0b013e3182330d8c
In Response
Rady and Verheijde 1 suggest that we made an incorrect or unreliable analysis with our data concerning the relationship between time of administration of opioids and sedatives and the time until death. 2 This concern is surprising, however, because as mentioned in the Limitations section, we deliberately refrained from a statistical analysis. Because several other studies did show that in terminally ill patients the contribution of sedatives and opioids to the time until death is negative or cannot be proven, we used these results for our discussion. [3] [4] [5] The study referred to was not published when our article was accepted and deals with a different population than that discussed in our article. 6 Both Sequential Organ Failure Assessment and Acute Physiology and Chronic Health Evaluation scores are high in comparison with those of other studies. This logically implies that the incidence of multiple organ failure is high in our population. Together with the fact that treatment is withdrawn simultaneously and not consecutively, it is inevitable that patients die within a very short time.
We did not show data of the level of discomfort; however, the dosage range of sedatives and opioids 4 hours before death was not very different from the maximum dosages in the last hour, suggesting that the standard sedation and pain medication regimen was continued and not automatically increased after the withdrawal of (lifesustaining) treatment. The articles referred to discuss medication use in neonatology departments, again a totally different patient population.
Pharmacodynamics are indeed different in critically ill patients with multiorgan failure than in "normal" patients. The question however is, should we take these alterations into account when we already titrate medication until the desired effect is reached? Furthermore, to our knowledge, there are no studies assessing pharmacodynamics of sedatives and opioids in terminally ill intensive care unit patients to get a better dose-effect relationship, and we therefore would not know how to implement the advice given. DOI: 10.1213/ANE.0b013e3182330d9e
Super Glue-Stuck on You
To the Editor G urnaney et al. 1 describe great success using Dermabond (2-octyl cyanoacrylate glue) to decrease pericatheter leakage associated with continuous local anesthetic infusion. We note that the patients were discharged from the hospital with the catheter in situ and did not encounter any problems relating to removal of the catheter. 1 We report our difficulties in 3 patients. We are a tertiary pediatric center and routinely use continuous perineural infusions for perioperative analgesia. We too have had problems with premature displacement or removal of the catheter in our population, especially in the upper limb. In response, we tried various combinations of suturing/subcutaneous tunneling/tissue glue in an attempt to prolong catheter survival. Combining tunneling with tissue glue seemed to be the most mechanically stable. We used n-butyl-2-cyanoacrylate monomer (Indermil Tissue Adhesive; Henkel Ltd., Dublin, Ireland) to secure the catheter to the skin.
We have encountered difficulty in the removal of the catheter in 3 children in whom Indermil was used in combination with tunneling. A reasonable (moderate) amount of force was required to remove the catheters resulting in considerable distress to the patients in 2 cases, while the third required general anesthesia for catheter removal. We did not encounter a similar problem when catheters were tunneled and sutured before our introduction of Indermil glue.
Suggestions have been made in the literature regarding the use of warm soapy water, 2,3 acetone, 2, 3 or petroleum
